Spironolactone prescribing `safe' in UK NHS setting

Author：

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.604, 2010-01, pp. : 9-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Spironolactone prescribing `safe' in UK NHS setting

Reactions Weekly, Vol. 1, Iss. 1303, 2010-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Challenges for the UK NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 656, 2012-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Safe prescribing, rocket science and consumers

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 48, Iss. 1, 2018-02 ,pp. : 4-6

John Wiley & Sons Inc

Access to resources Recommend Favorite

The UK NHS rationing debate goes on

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 306, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Extra billion earmarked for UK NHS

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 305, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite